 Health Care |
Health Care |
|
|
Where do House Speaker candidates stand on health care? |
Whoever wins the gavel will face a host of unfinished health care issues, including appropriations bills, a potential health transparency package and programs that expired at the end of last month.
|
Neither of the two main candidates, Reps. Steve Scalise (R-La.) and Jim Jordan (R-Ohio), are well-known as health policy experts. However, Scalise has served on the Energy and Commerce Committee since 2009 and only left this year to join GOP leadership and become majority leader. He has been an outspoken opponent of the Affordable Care Act for years and was a co-sponsor of the main GOP ObamaCare replacement legislation in the House. Scalise also served on the House coronavirus select subcommittee and has blasted the Biden administration's handling of the pandemic. Jordan, as founder of the House Freedom Caucus, helped push the ObamaCare replacement further to the right. He currently serves as Judiciary Committee chairman, where he's probed the administration's COVID-19 response. As part of an investigation into a COVID-19 "censorship regime" in the Executive Branch, Jordan sought information from drug company executives to find out the extent of their involvement. Jordan has also focused on investigating the origins of COVID-19 and publicly blamed former National Institute of Allergy and Infectious Diseases head Anthony Fauci for allegedly covering up that it came from a Chinese lab. Both Jordan and Scalise have stayed true to the GOP party line on abortion, with Scalise sitting on the House Pro-Life Caucus. Scalise received an "A" from influential anti-abortion group Susan B. Anthony Pro-Life America, while Jordan received an "A+." As a comparison, former Speaker Kevin McCarthy (R-Calif.) also received an "A" grade. Both Scalise and Jordan have also focused on securing the southern border as a way to control the flow of fentanyl into the country. |
Welcome to The Hill's Health Care newsletter, we're Nathaniel Weixel and Joseph Choi — every week we follow the latest moves on how Washington impacts your health. |
|
|
How policy will be impacting the health care sector this week and beyond: |
|
|
Next year's Medicare Part B premiums are expected to be announced soon and there is speculation that coverage of another pricey new Alzheimer's medication could cause monthly costs to go up, echoing what occurred in 2022. Leqembi received full approval from the Food and Drug Administration (FDA) in July, becoming the second drug of its kind to hit the market after Aduhelm. The drug comes with an annual cost of $26,500. While … |
| |
| The Biden administration on Friday extended flexibilities regarding controlled substances to be prescribed via telemedicine. The Drug Enforcement Administration (DEA) said in a notice it would allow providers to continue using telemedicine to prescribe certain controlled substances through the end of 2024. The temporary rule is meant “to ensure a smooth transition for patients and practitioners that have come … |
| |
| Research published Friday shows various acute respiratory infections, such as pneumonia, influenza and the common cold, may present with long-term symptoms, similar to COVID-19. "Long cold" symptoms could linger for up to four weeks in some cases, much like "long COVID," the UK-based researchers said. The study tracked more than 10,000 people with COVID and non-COVID illnesses and found all groups could get long-lasting symptoms. … |
| |
|
Branch out with a different read from The Hill: |
|
|
4 members of a Florida family are sentenced for selling a fake COVID-19 cure through online church |
MIAMI (AP) — A Florida man and his three adult sons were sentenced Friday for selling a toxic industrial bleach as a fake COVID-19 cure through their online church. A federal judge in Miami sentenced Jonathan Grenon, 37, and Jordan Grenon, 29, to 12 years and seven months in prison, while Mark Grenon, 66, and Joseph Grenon, 36, each received … |
|
|
Local and state headlines on health care: |
- State officials tout 'once in a lifetime' investment in North Carolina's mental health services (North Carolina Health News)
- Georgia will be first state with medical marijuana in pharmacies (WABE)
- Oregon health leaders warn of bumpy start for expanded Medicaid system (Oregon Capital Chronicle)
|
|
|
Health news we've flagged from other outlets: |
- Feds rein in use of predictive software that limits care for Medicare Advantage patients (KFF Health News)
- Pharmacies begin dispensing abortion pills (Politico)
- U.S. cancer centers report fewer drug shortages, but crisis continues (Axios)
|
|
|
Most read stories on The Hill right now: |
|
|
A New York appeals court declined to temporarily pause former President Trump's civil fraud trial but did halt the cancellation of Trump's … Read more |
| President Biden's decision this week to move forward with border wall construction that Democrats have long denounced shocked allies and immigration … Read more |
|
|
You're all caught up. See you next week! |
1625 K Street NW, 9th Floor, Washington, DC 20006 |
Copyright © 1998 - 2023 Nexstar Media Inc. | All Rights Reserved. |
|
|
|
If you believe this has been sent to you in error, please safely unsubscribe.
No comments:
Post a Comment